Trial intelligence / Profile preview

Levobupivacaine vs Ropivacaine for Pain Relief After Total Knee Replacement

NCT01172197Phase 4Terminated

Sponsor
NHS Tayside
Start
Jan 2009
Primary completion
Oct 2011
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by NHS Tayside. Started Jan 2009; status: terminated.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01172197.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01172197.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call